BRN Discussion Ongoing

Slade

Top 20
I doesn't do anything about the regulatory requirements, of being listed on the ASX in respect to disclosure though, which is one of the larger issues.

I previously strongly favored a dual listing, but it doesn't work, for that important reason.
Yes but the biggest issue is for those holding shares in super. Imagine being a loyal supporter of the company and holding shares for years and riding all the ups and downs only to be forced to sell at a loss. The share price will need to be significantly higher before these shareholders can get the return on investment that they deserve.
 
  • Like
  • Fire
Reactions: 25 users

HopalongPetrovski

I'm Spartacus!
As expected, even this positive news isn’t moving anything anymore. People just want to see cash. Partnerships don’t interest anyone anymore. And the short sellers have an easy game, as always. 🤷🏻‍♂️
Partnerships are great. Building the eco system is great. Being in universities is great. Having solid patent protection is great.
I like and endorse all those things and they make sense to me.
If we were living in the Star Trek universe, they would all probably be sufficient and we could just get on exploring the universe.

But in this one, where small investors back companies with an understanding that they will be compensated for the use of their capital and the risk undertaken, eventually the Company must be able to at least stand on it's own feet and that involves bringing in more revenue than it takes to fund the operation.
We are now well over 3 years into Sean's 5 year plan.
It's time to see us making some progress towards commercial adoption.
ISL and RTX are nice nibbles and will hopefully prove our worth and allow us further traction and adoption within these companies.
I'm also happy for us to be continuing our R&D and expanding our product range, particularly in light of customer feedback.

But the fact remains that Sean was bought onboard to commercialise us and our product and that has been the promise and supposedly the emphasis for at least the last two years.
I'd appreciate some straight talk from Sean about where we are at commercially.
I'm not asking him to predict the future, but an honest disclosure of our progress in relation to his plan thus far, would go some way towards restoring his credibility, which, in my eyes anyway, is wearing thin.
 
Last edited:
  • Like
  • Fire
  • Love
Reactions: 50 users

DK6161

Regular
As expected, even this positive news isn’t moving anything anymore. People just want to see cash. Partnerships don’t interest anyone anymore. And the short sellers have an easy game, as always. 🤷🏻‍♂️
Yep, I just want my money back. I would like to reinvest in other stocks while they are slightly discounted at this moment.
We have so many partnerships and collaborations, and they have produced nothing so far. So for me these little news don't mean anything anymore.
 
  • Fire
  • Like
  • Thinking
Reactions: 4 users

7für7

Top 20
Partnerships are great. Building the eco system is great. Being in universities is great. Having solid patent protection is great.
I like and endorse all those things and they make sense to me.
If we were living in the Star Trek universe, they would all probably be sufficient and we could just get on exploring the universe.

But in this one, where small investors back companies with an understanding that they will be compensated for the use of their capital and the risk undertaken, eventually the Company must be able to at least stand on it's own feet and that involves bringing in more revenue than it takes to fund the operation.
We are now well over 3 years into Sean's 5 year plan.
It's time to see us making some progress towards commercial adoption.
ISL and RTX are nice nibbles and will hopefully prove our worth and allow us further traction and adoption within these companies.
I'm also happy for us to be continuing our R&D and expanding our product range, particularly in light of customer feedback.

But the fact remains that Sean was bought onboard to commercialise us and our product and that has been the promise and supposedly the emphasis for at least the last two years.
I'd appreciate some straight talk from Sean about where we are at commercially.
I'm not asking him to predict the future, but an honest disclosure of our progress in relation to his plan thus far, would go some way towards restoring his credibility, which, in my eyes anyway, is wearing thin.
That’s exactly what I mean. I completely agree with you.

It’s one thing to be an AI enthusiast and to be satisfied with the company’s progress and its various partnerships—I personally am as well. But the other side of the coin is that I am not an employee of the company. I don’t receive a monthly salary, nor do I get millions of shares handed to me for free. We are all invested with our own money.

I’m tired of constantly leaving the market to the short sellers—the ones who have no faith in the company and laugh in our faces as investors. I’m tired of us, as supporters of the company, having to sugarcoat our investment every day, posting motivational messages, and hoping that we’re included here or there.

I’m not going to judge whether management is doing a bad job, because as an entrepreneur myself, I know how difficult it is to prove yourself in highly competitive markets. However, it is time to create some transparency and finally lay the cards on the table. This secrecy is just ridiculous—as if we were dealing with classified information on the level of national security.

Just tell us where we stand and whether concrete revenue is in sight. It’s no secret that landing a major licensee could make us profitable overnight. That applies to any startup when a big player steps in. The real question is whether such a licensee is actually in the pipeline or if that was just a generic statement.

that’s all
 
  • Like
  • Fire
  • Love
Reactions: 12 users

Newk R

Regular
This is a good point. A dual listing would allow those shareholders who hold shares in self managed super funds to keep hold of their shares rather than being forced to sell at a dismal share price.
I didn't think SMSFs had to sell?? Am I mistaken??
 

Slade

Top 20
I didn't think SMSFs had to sell?? Am I mistaken??
This is what I have heard from some shareholders that hold shares in SMSFs. From the little research that I’ve done it seems to be correct. But I think anyone in this situation should make the necessary enquiries and find out if it applies to them. It would be good to hear what others have found out.
 
  • Like
Reactions: 1 users

Deadpool

Did someone say KFC
This is what I have heard from some shareholders that hold shares in SMSFs. From the little research that I’ve done it seems to be correct. But I think anyone in this situation should make the necessary enquiries and find out if it applies to them. It would be good to hear what others have found out.
I have a SMSF and can invest in International shares but I believe it is some of the Australian Industry super funds that wont allow it.
 
  • Like
Reactions: 11 users

Iseki

Regular
Yep, I just want my money back. I would like to reinvest in other stocks while they are slightly discounted at this moment.
We have so many partnerships and collaborations, and they have produced nothing so far. So for me these little news don't mean anything anymore.
Just vote no to redomeciling unless the board can bring in a whale investor to buy 5% of company and ensure profitability so the SP tops 60c before the move.
 
  • Like
Reactions: 9 users

Tarrawan

Emerged
Just vote no to redomeciling unless the board can bring in a whale investor to buy 5% of company and ensure profitability so the SP tops 60c before the move.
Bye Bye .
 

Zedjack33

Regular
This is what I have heard from some shareholders that hold shares in SMSFs. From the little research that I’ve done it seems to be correct. But I think anyone in this situation should make the necessary enquiries and find out if it applies to them. It would be good to hear what others have found out.
QSuper won’t allow.
 
  • Like
Reactions: 1 users

Diogenese

Top 20
Partnerships are great. Building the eco system is great. Being in universities is great. Having solid patent protection is great.
I like and endorse all those things and they make sense to me.
If we were living in the Star Trek universe, they would all probably be sufficient and we could just get on exploring the universe.

But in this one, where small investors back companies with an understanding that they will be compensated for the use of their capital and the risk undertaken, eventually the Company must be able to at least stand on it's own feet and that involves bringing in more revenue than it takes to fund the operation.
We are now well over 3 years into Sean's 5 year plan.
It's time to see us making some progress towards commercial adoption.
ISL and RTX are nice nibbles and will hopefully prove our worth and allow us further traction and adoption within these companies.
I'm also happy for us to be continuing our R&D and expanding our product range, particularly in light of customer feedback.

But the fact remains that Sean was bought onboard to commercialise us and our product and that has been the promise and supposedly the emphasis for at least the last two years.
I'd appreciate some straight talk from Sean about where we are at commercially.
I'm not asking him to predict the future, but an honest disclosure of our progress in relation to his plan thus far, would go some way towards restoring his credibility, which, in my eyes anyway, is wearing thin.
Hi Hoppy,

The sad fact is that the company gets $0.00 from shares bought on market. IPO aside, it is only when new shares are offered that the company gets any money from share sales.

I'd like to see a system where the company gets a small percent of each on market sale. That way, bot trading and shorting would provide some little benefit the company.

It's good to get a couple of radar partnerships in a couple of days. Tony Lewis linked the ILS partnership with TENNs. I think that the Raytheon/AFRL micro-doppler project will also employ TENNs.

Funny thing, the SBIR site has a short memory: (Maybe they are using Signal.)

https://www.islinc.com/national-security
,,,
ISL has an impressive record of transitioning advanced technologies to the field. In the last few years alone, ISL has been awarded three (3) Phase III SBIR contracts, and has been featured twice as an SBIR Success Story (see for example https://www.sbir.gov/node/1526807).

https://www.sbir.gov/node/1526807
...
The requested page could not be found.

Interestingly Joe Guerci is a pre-Trump-appointed Special Government Employee:

https://www.linkedin.com/in/joe-guerci-505aa26/

Special Government Employee (SGE)
US Army · Part-time Nov 2024 - Present · 6 mos

    • Consultant to Army Science Board
 
  • Like
  • Fire
  • Thinking
Reactions: 25 users
What time is Nintendo releasing their specifications today anyone please ?
 

Schwale

Regular
What time is Nintendo releasing their specifications today anyone please ?

NINTENDO SWITCH 2 NINTENDO DIRECT TIMES AUSTRALIA​

The Nintendo Direct for the Nintendo Switch 2 will be taking place on Thursday April 3rd (Melbourne/Sydney) or Wednesday, April 2nd (rest of Australia). The Direct will last 60 minutes in length

  • Thursday 00:00 AEDT (Melbourne/Sydney/Hobart/Canberra)
  • Wednesday 11:30pm ACDT (Adelaide)
  • Wednesday 11:00pm AEST (Brisbane)
  • Wednesday 10:30pm ACST (Darwin)
  • Wednesday 9:00pm AWST (Perth)
 
  • Like
  • Love
  • Fire
Reactions: 13 users

Bravo

If ARM was an arm, BRN would be its biceps💪!

View attachment 81092


I just listed to to this podcast, which was recorded two days ago with Ilay Marom from Nanose Medical.

In the podcast Ilay discusses Nanose's non-invasive hand-held breath test which can provide early detection of Metabolic dysfunction-associated steatotic liver disease (MASLD). He talks about how it can do via a sensor array using a pattern recognition algorithm. He believes the device will be a "game-changer" because it can be used everywhere.

He talks about the how the technology was invented over a decade ago at Technion Israel Institute of Technology by Prof. Hossam Haick.

When asked to explain the technology he talked a bit about nano particles but he said he couldn't talk about what was different about their sensors because part of it is confidential. He mentioned that there are 7 patents for the technology held by Technion, 1 patent is Nanose own and there another 4 patents pending.

Ilay repeated that the way they produce their sensor is not patented, that instead it's a "trade secret". He describes it being the secret sauce, like the Coca-Cola recipe.

Nanose are hoping to bring this device to the market by 2026 to detect MASLD (fatty liver disease) and then expect to be able to bring another variation to market to detect lung disease by 2027.

Asked about their 5 year plan, Ilay said he hopes the device will be in every clinic and that it will save millions of lives and billions of dollars.

If I'm not mistaken, I recall that a few years ago Nanose had some sort of issue with the manufacturing of the sensors that meant they couldn't achieve consistent results, so they must have somehow overcome this issue, which is great new.

I also remember someone from this forum saying they had spoken to PVDM after the 2022 AGM and Peter had apparently confirmed that the problem was only with the sensor and not with our technology. I don't know if anyone else has more information to add about whether this is correct?

For convenience I've also attached Rich Wawrzyniak's 2021 Nanose/BrainChip Blog. It shows a list of diseases detected with the Nanose device. Curiously MASLD isn't one of them.

Screenshot 2025-04-02 at 4.40.16 pm.png




The above Semico article is also still displayed on our website, if that means anything.


Screenshot 2025-04-02 at 5.19.20 pm.png
 
  • Like
  • Fire
  • Love
Reactions: 48 users

NINTENDO SWITCH 2 NINTENDO DIRECT TIMES AUSTRALIA​

The Nintendo Direct for the Nintendo Switch 2 will be taking place on Thursday April 3rd (Melbourne/Sydney) or Wednesday, April 2nd (rest of Australia). The Direct will last 60 minutes in length

  • Thursday 00:00 AEDT (Melbourne/Sydney/Hobart/Canberra)
  • Wednesday 11:30pm ACDT (Adelaide)
  • Wednesday 11:00pm AEST (Brisbane)
  • Wednesday 10:30pm ACST (Darwin)
  • Wednesday 9:00pm AWST (Perth)
Thanks mate
 
  • Like
Reactions: 1 users

manny100

Top 20
Hi Hoppy,

The sad fact is that the company gets $0.00 from shares bought on market. IPO aside, it is only when new shares are offered that the company gets any money from share sales.

I'd like to see a system where the company gets a small percent of each on market sale. That way, bot trading and shorting would provide some little benefit the company.

It's good to get a couple of radar partnerships in a couple of days. Tony Lewis linked the ILS partnership with TENNs. I think that the Raytheon/AFRL micro-doppler project will also employ TENNs.

Funny thing, the SBIR site has a short memory: (Maybe they are using Signal.)

https://www.islinc.com/national-security
,,,
ISL has an impressive record of transitioning advanced technologies to the field. In the last few years alone, ISL has been awarded three (3) Phase III SBIR contracts, and has been featured twice as an SBIR Success Story (see for example https://www.sbir.gov/node/1526807).

https://www.sbir.gov/node/1526807
...
The requested page could not be found.

Interestingly Joe Guerci is a pre-Trump-appointed Special Government Employee:

https://www.linkedin.com/in/joe-guerci-505aa26/

Special Government Employee (SGE)
US Army · Part-time Nov 2024 - Present · 6 mos
    • Consultant to Army Science Board
Even a minimal order amount would stop the ridiculous minimal share transactions. No many genuine participants would buy/sell less than $???
Bot order systems are clearly designed to take money from retailers.
 
  • Like
Reactions: 7 users

manny100

Top 20
I just listed to to this podcast, which was recorded two days ago with Ilay Marom from Nanose Medical.

In the podcast Ilay discusses Nanose's non-invasive hand-held breath test which can provide early detection of Metabolic dysfunction-associated steatotic liver disease (MASLD). He talks about how it can do via a sensor array using a pattern recognition algorithm. He believes the device will be a "game-changer" because it can be used everywhere.

He talks about the how the technology was invented over a decade ago at Technion Israel Institute of Technology by Prof. Hossam Haick.

When asked to explain the technology he talked a bit about nano particles but he said he couldn't talk about what was different about their sensors because part of it is confidential. He mentioned that there are 7 patents for the technology held by Technion, 1 patent is Nanose own and there another 4 patents pending.

Ilay repeated that the way they produce their sensor is not patented, that instead it's a "trade secret". He describes it being the secret sauce, like the Coca-Cola recipe.

Nanose are hoping to bring this device to the market by 2026 to detect MASLD (fatty liver disease) and then expect to be able to bring another variation to market to detect lung disease by 2027.

Asked about their 5 year plan, Ilay said he hopes the device will be in every clinic and that it will save millions of lives and billions of dollars.

If I'm not mistaken, I recall that a few years ago Nanose had some sort of issue with the manufacturing of the sensors that meant they couldn't achieve consistent results, so they must have somehow overcome this issue, which is great new.

I also remember someone from this forum saying they had spoken to PVDM after the 2022 AGM and Peter had apparently confirmed that the problem was only with the sensor and not with our technology. I don't know if anyone else has more information to add about whether this is correct?

For convenience I've also attached Rich Wawrzyniak's 2021 Nanose/BrainChip Blog. It shows a list of diseases detected with the Nanose device. Curiously MASLD isn't one of them.

View attachment 81097



The above Semico article is also still displayed on our website, if that means anything.


View attachment 81098
Great article, thanks, looks like many diseases are detectable but i guess still waiting on Health approvals.
 
  • Like
Reactions: 3 users

Tezza

Regular
  • Like
Reactions: 4 users

CHIPS

Regular
Partnerships are great. Building the eco system is great. Being in universities is great. Having solid patent protection is great.
I like and endorse all those things and they make sense to me.
If we were living in the Star Trek universe, they would all probably be sufficient and we could just get on exploring the universe.

But in this one, where small investors back companies with an understanding that they will be compensated for the use of their capital and the risk undertaken, eventually the Company must be able to at least stand on it's own feet and that involves bringing in more revenue than it takes to fund the operation.
We are now well over 3 years into Sean's 5 year plan.
It's time to see us making some progress towards commercial adoption.
ISL and RTX are nice nibbles and will hopefully prove our worth and allow us further traction and adoption within these companies.
I'm also happy for us to be continuing our R&D and expanding our product range, particularly in light of customer feedback.

But the fact remains that Sean was bought onboard to commercialise us and our product and that has been the promise and supposedly the emphasis for at least the last two years.
I'd appreciate some straight talk from Sean about where we are at commercially.
I'm not asking him to predict the future, but an honest disclosure of our progress in relation to his plan thus far, would go some way towards restoring his credibility, which, in my eyes anyway, is wearing thin.

Who is getting a guarantee at the stock market to make a profit and expects this? It is always a risk and I often lost money in the past because companies were sold or taken out of business. Nobody asked me whether I had been in the green when this happened and nobody compensated me for it. If one cannot live with this, one should not buy stocks.
 
  • Like
  • Love
Reactions: 3 users

Diogenese

Top 20
Great article, thanks, looks like many diseases are detectable but i guess still waiting on Health approvals.
Hi Bravo,

Yes. It's taken Nanose a while to sort out the nanotech manufacture. Back then, the test was run on Akida with stored Nanose results, but they mentioned that they had to cut a significant number of results before the test because they were erroneous. So I guess their "secret sauce" improvements have improved consistency and accuracy.
 
  • Like
Reactions: 11 users
Top Bottom